CEN BIOTECH INC Quarterly Debt-to-equity in % from Q3 2016 to Q3 2022

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cen Biotech Inc quarterly Debt-to-equity history and growth rate from Q3 2016 to Q3 2022.
  • Cen Biotech Inc Debt-to-equity for the quarter ending September 30, 2022 was -533 %, a 173% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2022 -533 -338 -173% Sep 30, 2022
Q2 2022 -489 -343 -235% Jun 30, 2022
Q1 2022 -369 -236 -176% Mar 31, 2022
Q4 2021 -245 -116 -90% Dec 31, 2021
Q3 2021 -195 -69.4 -55.2% Sep 30, 2021
Q2 2021 -146 -18.5 -14.5% Jun 30, 2021
Q1 2021 -134 -4.35 -3.37% Mar 31, 2021
Q4 2020 -129 +2.12 +1.62% Dec 31, 2020
Q3 2020 -126 +6.78 +5.12% Sep 30, 2020
Q2 2020 -128 +9.2 +6.73% Jun 30, 2020
Q1 2020 -129 +12.4 +8.75% Mar 31, 2020
Q4 2019 -131 Dec 31, 2019
Q3 2019 -132 Sep 30, 2019
Q2 2019 -137 Jun 30, 2019
Q1 2019 -142 Mar 31, 2019
Q4 2017 -131 +66.5 +33.7% Dec 31, 2017
Q3 2017 -133 +94.4 +41.6% Sep 30, 2017
Q2 2017 -148 Jun 30, 2017
Q1 2017 -169 Mar 31, 2017
Q4 2016 -198 Dec 31, 2016
Q3 2016 -227 Sep 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.